Benzinga | May 6, 2021 05:05PM EDT

Dicerna Pharmaceuticals Q1 EPS $(0.39) Misses $(0.37) Estimate, Sales $47.60M Beat $46.28M Estimate

Dicerna Pharmaceuticals (NASDAQ:DRNA) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 25.81 percent decrease over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $47.60 million which beat the analyst consensus estimate of $46.28 million by 2.86 percent. This is a 39.89 percent increase over sales of $34.03 million the same period last year.